These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8083353)

  • 1. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
    Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER
    J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.
    Hussain MA; Schmitz O; Mengel A; Keller A; Christiansen JS; Zapf J; Froesch ER
    J Clin Invest; 1993 Nov; 92(5):2249-56. PubMed ID: 8227340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
    Pascual M; Larralde J; Martínez JA
    Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.
    Yakar S; Setser J; Zhao H; Stannard B; Haluzik M; Glatt V; Bouxsein ML; Kopchick JJ; LeRoith D
    J Clin Invest; 2004 Jan; 113(1):96-105. PubMed ID: 14702113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
    Alford FP; Hew FL; Christopher MC; Rantzau C
    J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R; Ninnis R; Keller U
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V
    Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men.
    Gibney J; Wolthers T; Johannsson G; Umpleby AM; Ho KK
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E266-71. PubMed ID: 15727949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
    Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL; Jackson NC; Shojaee-Moradie F; Jones RH; Russell-Jones DL; Sönksen PH; Dunger DB; Umpleby AM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis.
    Shmueli E; Stewart M; Alberti KG; Record CO
    Hepatology; 1994 Feb; 19(2):322-8. PubMed ID: 7904978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR; Smith-Banks A; Underwood LE
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth hormone on glucose metabolism.
    Møller N; Jørgensen JO; Abildgård N; Orskov L; Schmitz O; Christiansen JS
    Horm Res; 1991; 36 Suppl 1():32-5. PubMed ID: 1806481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.